7GQ logo

Paragon 28 DB:7GQ Stock Report

Last Price

€11.40

Market Cap

€963.8m

7D

0%

1Y

26.0%

Updated

21 Apr, 2025

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

7GQ Stock Overview

Develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. More details

7GQ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Paragon 28, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Paragon 28
Historical stock prices
Current Share PriceUS$11.40
52 Week HighUS$12.80
52 Week LowUS$4.06
Beta1.47
1 Month Change-4.20%
3 Month Change9.62%
1 Year Change25.97%
3 Year Change-32.14%
5 Year Changen/a
Change since IPO-25.24%

Recent News & Updates

Recent updates

Shareholder Returns

7GQDE Medical EquipmentDE Market
7D0%0.8%0.8%
1Y26.0%-9.3%15.0%

Return vs Industry: 7GQ exceeded the German Medical Equipment industry which returned -14.6% over the past year.

Return vs Market: 7GQ exceeded the German Market which returned 8.4% over the past year.

Price Volatility

Is 7GQ's price volatile compared to industry and market?
7GQ volatility
7GQ Average Weekly Movement4.2%
Medical Equipment Industry Average Movement6.3%
Market Average Movement6.5%
10% most volatile stocks in DE Market12.8%
10% least volatile stocks in DE Market3.1%

Stable Share Price: 7GQ has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 7GQ's weekly volatility has decreased from 11% to 4% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010525Albert DaCostaparagon28.com

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system. It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix.

Paragon 28, Inc. Fundamentals Summary

How do Paragon 28's earnings and revenue compare to its market cap?
7GQ fundamental statistics
Market cap€963.77m
Earnings (TTM)-€47.95m
Revenue (TTM)€224.83m
4.3x
P/S Ratio
-20.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7GQ income statement (TTM)
RevenueUS$256.18m
Cost of RevenueUS$64.69m
Gross ProfitUS$191.49m
Other ExpensesUS$246.13m
Earnings-US$54.64m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.65
Gross Margin74.75%
Net Profit Margin-21.33%
Debt/Equity Ratio84.8%

How did 7GQ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/21 03:29
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Paragon 28, Inc. is covered by 3 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Neil ChatterjiB. Riley Securities, Inc.
David TurkalyCitizens JMP Securities, LLC
Michael MatsonNeedham & Company